• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].

作者信息

Olin P

机构信息

Vaccinforskningsenheten, Smittskyddsinstitutet, Solna.

出版信息

Lakartidningen. 2001 Aug 29;98(35):3654-7.

PMID:11577639
Abstract

The Swedish vaccination programme against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b is characterized by few, widely spaced doses. Swedish schoolchildren have low diphtheria antibody levels compared to children in other countries. The introduction of acellular pertussis vaccine in 1996 has markedly cut the pertussis incidence in all ages except school-age children. There are now reasons to consider replacing the present fourth dose of inactivated polio vaccine given at 5 years of age and the diphtheria-tetanus toxoids given at 10 years of age with a combined diphtheria-tetanus-polio-acellular pertussis vaccine dose to be given at 5-6 years of age. A fifth dose of a DTPaPolio vaccine should be considered at 15-18 years of age.

摘要

相似文献

1
[Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
Lakartidningen. 2001 Aug 29;98(35):3654-7.
2
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.一种青少年-成人剂型的吸附破伤风和白喉类毒素与无细胞百日咳疫苗联合制剂,在4至6岁儿童中与一种儿科剂型的无细胞百日咳疫苗及吸附白喉和破伤风类毒素与灭活脊髓灰质炎疫苗联合制剂相比,具有相当的免疫原性,但反应原性较低。
Vaccine. 2007 Jan 22;25(6):1121-5. doi: 10.1016/j.vaccine.2006.09.053. Epub 2006 Oct 2.
3
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.1998 - 2001年美国6至59个月大儿童的百日咳疫苗效力
Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759.
4
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.对2岁以下儿童同时接种甲型肝炎灭活疫苗与白喉-破伤风-无细胞百日咳疫苗和B型流感嗜血杆菌疫苗的免疫原性和安全性。
Pediatrics. 2006 Sep;118(3):e602-9. doi: 10.1542/peds.2005-2755.
5
[Time for booster doses against whooping cough for 10-year-old children].[10岁儿童百日咳加强针接种时间]
Lakartidningen. 2005;102(35):2394-8.
6
A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.白喉、破伤风、五组分无细胞百日咳、脊髓灰质炎病毒和b型流感嗜血杆菌联合疫苗
Expert Rev Vaccines. 2005 Dec;4(6):793-805. doi: 10.1586/14760584.4.6.793.
7
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防:破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
8
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.
9
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.在一个大型管理式医疗组织中,基于人群的白喉、破伤风、无细胞百日咳、乙型肝炎和灭活脊髓灰质炎联合疫苗上市后安全性评估。
Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.
10
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗(dTpa-IPV)用于成人加强免疫接种。
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.